Group One Trading
LUMO

Group One Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Group One Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-73,200
Closed -$1.21M – 6634
2020
Q2 		$1.21M Sell
73,200
-100
-0.1% -$1.19K 0.01% 1866
2020
Q1 		$623K Buy
73,300
+50,289
+219% +$703K 0.01% 1890
2019
Q4 		$524K Sell
23,011
-3,689
-14% -$52.6K ﹤0.01% 2387
2019
Q3 		$382K Buy
26,700
+26,544
+17,015% +$389K ﹤0.01% 2559
2019
Q2 		$2K Buy
+156
New +$2.36K ﹤0.01% 4778
2018
Q4 		– Sell
-1,389
Closed -$30K – 5523
2018
Q3 		$30K Sell
1,389
-7,467
-84% -$227K ﹤0.01% 4236
2018
Q2 		$379K Buy
8,856
+4,223
+91% +$193K ﹤0.01% 2531
2018
Q1 		$302K Sell
4,633
-2,400
-34% -$170K ﹤0.01% 2451
2017
Q4 		$513K Buy
7,033
+4,422
+169% +$366K ﹤0.01% 2232
2017
Q3 		$239K Sell
2,611
-400
-13% -$30.7K ﹤0.01% 2639
2017
Q2 		$199K Buy
3,011
+744
+33% +$92.1K ﹤0.01% 2648
2017
Q1 		$492K Buy
2,267
+1,123
+98% +$160K 0.01% 1858
2016
Q4 		$106K Sell
1,144
-112
-9% -$12.6K ﹤0.01% 2814
2016
Q3 		$170K Sell
1,256
-133
-10% -$13.2K ﹤0.01% 2582
2016
Q2 		$141K Sell
1,389
-3,467
-71% -$430K ﹤0.01% 2639
2016
Q1 		$795K Sell
4,856
-6,933
-59% -$1.41M 0.01% 1343
2015
Q4 		$3.86M Sell
11,789
-1,967
-14% -$640K 0.05% 486
2015
Q3 		$4.44M Buy
13,756
+1,578
+13% +$693K 0.06% 389
2015
Q2 		$4.85M Sell
12,178
-10,444
-46% -$4.44M 0.07% 343
2015
Q1 		$11.1M Buy
22,622
+7,466
+49% +$2.89M 0.17% 90
2014
Q4 		$5.42M Buy
15,156
+5,123
+51% +$1.52M 0.08% 259
2014
Q3 		$1.93M Buy
10,033
+2,033
+25% +$447K 0.03% 709
2014
Q2 		$1.91M Sell
8,000
-7,078
-47% -$1.44M 0.03% 728
2014
Q1 		$3.85M Sell
15,078
-4,455
-23% -$1.36M 0.06% 317
2013
Q4 		$3.87M Buy
19,533
+6,655
+52% +$1.18M 0.06% 342
2013
Q3 		$2.18M Buy
12,878
+10,622
+471% +$1.71M 0.04% 515
2013
Q2 		$400K Buy
+2,256
New +$319K 0.01% 1533

Other funds holding LUMO

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading's LUMO Position: Q2 2024 in Review

Group One Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2024, closing a stake of 150 shares — an estimated $423 sold.

Group One Trading first reported a position in LUMO in Q4 2013 and held it in 36 quarters. The position peaked at $3.35M in Q1 2015. 35 funds tracked by Wall St. Rank hold LUMO as of Q2 2024.

  • Group One Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 150 Lumos Pharma, Inc. Common Stock shares in Q2 2024, an estimated $423.
  • Group One Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 36 quarters.
  • Group One Trading's Lumos Pharma, Inc. Common Stock position peaked at $3.35M in Q1 2015.
  • 35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.